Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure.

Publication Type:

Journal Article


Annals of internal medicine, Volume 160, Issue 10, p.672-83 (2014)


2014, Center-Authored Paper, Clinical Research Division, Institute for Cancer Outcomes Research and Evaluation (ICORE), June 2014, Public Health Sciences Division


Childhood cancer survivors treated with anthracyclines are at high risk for asymptomatic left ventricular dysfunction (ALVD), subsequent heart failure, and death. The consensus-based Children's Oncology Group (COG) Long-Term Follow-up Guidelines recommend lifetime echocardiographic screening for ALVD.